Recent Advance in the Design of Small Molecular Modulators of Estrogen-Related Receptors
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
The estrogen-related receptors (ERRs), comprising ERRα, ERRβ and ERRγ, are the members of the nuclear receptor superfamily, which have been functionally implicated in estrogen signal pathway in various patterns. However, no natural ligand of ERRs has been identified to data, so identification of the synthetic modulators (inverse agonist and agonist) of ERRs would be highly effective in the treatment of estrogen-related pathologies, such as diabetes, breast cancer and osteoporosis. This review summarizes the structures and biological functions of ERR subtypes, and the progress in designing the small molecular modulators of ERRs as well as the detailed description of available co-crystal structures of the LBD of ERRs in three distinct states: unligand, inverse agonist bound, and agonist bound.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ERα plays a major role in the activity of adipocytes and sexual dimorphism of fat distribution.”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [65]
In the citing paper
“Female and male mice that lack ERα have central obesity, have severe insulin resistance, and are diabetic [63–65].”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [65]
Citations
Cites
Puigserver, P., & Spiegelman, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0012 · Cited by 2,076 · cited 1×
“The former, PGC-1 was a central regulator of genes involved in glucose and fatty acids metabolism in the process of mitochondrial oxidative phosphorylation (OXPHOS) [37].”
BackgroundAnatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network
Bookout, A. L., Jeong, Y., Downes, M., Yu, R. T., Evans, R. M., & Mangelsdorf, D. J. (2006) · Cell · doi:10.1016/j.cell.2006.06.049 · Cited by 1,015 · cited 1×
“Furthermore, the three ERR isoforms are expressed ubiquitously and distinctly in the tissues [17,18].”
BackgroundNuclear Receptor Expression Links the Circadian Clock to Metabolism
Yang, X., Downes, M., Yu, R. T., Bookout, A. L., He, W., Straume, M., Mangelsdorf, D. J., & Evans, R. M. (2006) · Cell · doi:10.1016/j.cell.2006.06.050 · Cited by 934 · cited 1×
“Furthermore, the three ERR isoforms are expressed ubiquitously and distinctly in the tissues [17,18].”
BackgroundIdentification of a new class of steroid hormone receptors
Giguère, V., Yang, N., Segui, P., & Evans, R. M. (1988) · Nature · doi:10.1038/331091a0 · Cited by 867 · cited 3×
“Since the ERRs was identified [2], there have been many different kinds of ERRs small molecular modulators discovered, which would be promising candidates in the treatment of cancer, osteoporosis, cardiovascular disease and diabetes, etc.”
BackgroundMethodOrphan Nuclear Receptors: From Gene to Function*
Giguère, V. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0378 · Cited by 855
Mootha, V. K., Handschin, C., Arlow, D., Xie, X., St. Pierre, J., Sihag, S., Yang, W., Altshuler, D., Puigserver, P., Patterson, N., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401401101 · Cited by 688 · cited 1×
“Extensive genetic and functional studies have highlighted ERR as the main player in oxidative metabolism, a pathway that contributes to the pathology of diabetes [6,7].”
BackgroundTranscriptional Control of Energy Homeostasis by the Estrogen-Related Receptors
Giguère, V. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0017 · Cited by 580 · cited 1×
“The ERR role in energy metabolism was demonstrated by two kinds of studies, functional genomics and biochemical studies, and ERR knockout mouse model studies [35,36].”
MethodHuss, J. M., Kopp, R. P., & Kelly, D. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206324200 · Cited by 479
Schreiber, S. N., Knutti, D., Brogli, K., Uhlmann, T., & Kralli, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212923200 · Cited by 457
To ERR in the estrogen pathway
Giguére, V. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(02)00592-1 · Cited by 401 · cited 1×
“However, ERRs homodimer can competitively bind to the ERs response elements (EREs) of the target gene due to the similarity in the DBD [33], thus affecting the estrogen signaling pathway[34].”
BackgroundSladek, R., Bader, J.-A., & Giguère, V. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5400 · Cited by 374 · cited 1×
“Moreover, PGC-1 and ERR interactions can also promote the transcription of the downstream genes mediumchain acyl Co-A dehydrogenase (MACD), a key enzyme that catalyzes the initial step in mitochondrial -oxidation of fatty acids [38,39].”
BackgroundReduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor α.
Luo, J., Sladek, R., Carrier, J., Bader, J.-A., Richard, D., & Giguère, V. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.7947-7956.2003 · Cited by 370
Adaptation of Energy Metabolism in Breast Cancer Brain Metastases
Chen, E. I., Hewel, J., Krueger, J. S., Tiraby, C., Weber, M. R., Kralli, A., Becker, K., Yates, J. R., & Felding-Habermann, B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3137 · Cited by 352 · cited 1×
“reported that the coordinated upregulation of ERR , its coactivators (PCG-1 and PCG-1 ) and genes involved in OXPHOS pathway was observed in a human breast cancer model for brain metastasis [46].”
BackgroundERRγ Directs and Maintains the Transition to Oxidative Metabolism in the Postnatal Heart
Alaynick, W. A., Kondo, R. P., Xie, W., He, W., Dufour, C. R., Downes, M., Jonker, J. W., Giles, W., Naviaux, R. K., Giguère, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.007 · Cited by 309
Hong, H., Yang, L., & Stallcup, M. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22618 · Cited by 303 · cited 1×
“One kind is that, ERRs are constitutively activated by p160 family of steroid receptor co-activators SRC-1 family (SRC-1, SRC-2, SRC-3) [26,27], the peroxisome proliferator-activated receptor coactivator-1 (PGC-1 , PGC-1 ) [28,29], and proline rich nuclear receptor co-regulatory protein 2 (PNRC2) [30,31], etc.”
BackgroundGreschik, H., Wurtz, J.-M., Sanglier, S., Bourguet, W., van Dorsselaer, A., Moras, D., & Renaud, J.-P. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00444-6 · Cited by 291
LIGAND CONTROL OF COREGULATOR RECRUITMENT TO NUCLEAR RECEPTORS
Nettles, K. W., & Greene, G. L. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.66.032802.154710 · Cited by 268 · cited 1×
“LBD is located at C terminal, including a ligand dependent transcriptional activation function-2 (AF-2) to control the interactions between receptor and co-regulatory proteins, thus regulating the transcriptional activity of ERRs [23].”
Background4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor γ
Coward, P., Lee, D., Hull, M. V., & Lehmann, J. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151244398 · Cited by 265 · cited 2×
“2) bound ERR with a Kd value of 35 nM and led to a selective inhibition of ERR transcriptional activity with IC50 value of 2 μM in cell-based assay [51].”
BackgroundMethodTremblay, G. B., Kunath, T., Bergeron, D., Lapointe, L., Champigny, C., Bader, J.-A., Rossant, J., & Giguère, V. (2001) · Genes & Development · doi:10.1101/gad.873401 · Cited by 255 · cited 1×
“first demonstrated that DES can antagonize ERRs by disrupting the interactions with co-regulator GRIP-1 with dose-dependent and IC50 value of 1 μM [50].”
BackgroundERRα: a metabolic function for the oldest orphan
Villena, J. A., & Kralli, A. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.07.005 · Cited by 252 · cited 1×
“The ERR role in energy metabolism was demonstrated by two kinds of studies, functional genomics and biochemical studies, and ERR knockout mouse model studies [35,36].”
MethodEstrogen receptor-related receptors: orphan receptors desperately seeking a ligand
Horard, B., & Vanacker, J. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0310349 · Cited by 249 · cited 2×
“Hence, the steroid ligand E2 does not bind to the LBP of ERRs to regulate the activity [4].”
BackgroundEstrogen-Related Receptor α in Human Breast Carcinoma as a Potent Prognostic Factor
Suzuki, T., Miki, Y., Moriya, T., Shimada, N., Ishida, T., Hirakawa, H., Ohuchi, N., & Sasano, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0250 · Cited by 219 · cited 2×
“Analysis of 102 clinical breast cancer samples by immunohistochemistry revealed that ERR protein was expressed in the nuclei of 55% of breast cancers [44].”
BackgroundKallen, J., Schlaeppi, J.-M., Bitsch, F., Filipuzzi, I., Schilb, A., Riou, V., Graham, A., Strauss, A., Geiser, M., & Fournier, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407999200 · Cited by 218
Willy, P. J., Murray, I. R., Qian, J., Busch, B. B., Stevens, W. C., Martin, R., Mohan, R., Zhou, S., Ordentlich, P., Wei, P., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401420101 · Cited by 196
Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors.
Suetsugi, M., Su, L., Karlsberg, K., Yuan, Y.-C., & Chen, S. (2003) · PubMed · Cited by 196
Busch, B. B., Stevens, Martin, R., Ordentlich, P., Zhou, S., Sapp, D. W., Horlick, R. A., & Mohan, R. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049334f · Cited by 173 · cited 1×
“4) [57].”
Estrogen-Related Receptors as Emerging Targets in Cancer and Metabolic Disorders
Ariazi, E., & Jordan, V. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026610606030203 · Cited by 168 · cited 3×
“In addition to this, ERR is also a therapeutic target in cancer [8,9] and osteoporosis [10].”
BackgroundVega, R. B., & Kelly, D. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31693 · Cited by 154 · cited 1×
“Moreover, PGC-1 and ERR interactions can also promote the transcription of the downstream genes mediumchain acyl Co-A dehydrogenase (MACD), a key enzyme that catalyzes the initial step in mitochondrial -oxidation of fatty acids [38,39].”
BackgroundXie, W. (1999) · Molecular Endocrinology · doi:10.1210/me.13.12.2151 · Cited by 151 · cited 1×
“One kind is that, ERRs are constitutively activated by p160 family of steroid receptor co-activators SRC-1 family (SRC-1, SRC-2, SRC-3) [26,27], the peroxisome proliferator-activated receptor coactivator-1 (PGC-1 , PGC-1 ) [28,29], and proline rich nuclear receptor co-regulatory protein 2 (PNRC2) [30,31], etc.”
BackgroundThe ERR-1 Orphan Receptor Is a Transcriptional Activator Expressed During Bone Development
Bonnelye, E., Vanacker, J. M., Dittmar, T., Begue, A., Desbiens, X., Denhardt, D. T., Aubin, J. E., Laudet, V., & Fournier, B. (1997) · Molecular Endocrinology · doi:10.1210/me.11.7.905 · Cited by 147 · cited 1×
“ERR is overexpressed in bone cells and cartilage cells [48], and directly regulates the expression of osteoblastassociated genes, such as osteopontin, lactoferrin, aromatase and endothelial nitric oxide synthase.”
BackgroundPatch, R. J., Searle, L. L., Kim, A. J., De, D., Zhu, X., Askari, H. B., O’Neill, J. C., Abad, M. C., Rentzeperis, D., Liu, J., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101063h · Cited by 141
Eudy, J. D., Yao, S., Weston, M. D., Ma-Edmonds, M., Talmadge, C. B., Cheng, J. J., Kimberling, W. J., & Sümegi, J. (1998) · Genomics · doi:10.1006/geno.1998.5345 · Cited by 140 · cited 1×
“[12].”
Wang, L., Zuercher, W. J., Consler, T. G., Lambert, M. H., Miller, A. B., Orband-Miller, L. A., McKee, D. D., Willson, T. M., & Nolte, R. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608410200 · Cited by 136 · cited 3×
“The hydroxyl of GSK4716 formed hydrogen bond with Asp328, while did not interact with reoriented Glu275 and Arg316 that are consistent with the phenol-binding residues in ERs [54].”
BackgroundThe NR3B Subgroup: An Overrview
Tremblay, A. M., & Giguère, V. (2007) · Nuclear Receptor Signaling · doi:10.1621/nrs.05009 · Cited by 134 · cited 4×
“Chemical structures of pyrido[1,2- ]pyrimidin-4-ones 39-48 as”
BackgroundInfluentialZhang, Z., & Teng, C. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001880200 · Cited by 134
Chen, J., & Nathans, J. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.07.011 · Cited by 131 · cited 1×
“ERR is mainly expressed in the early embryonic development and only can be found in the liver, stomach, skeletal muscle, heart and kidney with a small amount [19].”
BackgroundYang, C., & Chen, S. (1999) · PubMed · Cited by 130
Greschik, H., Flaig, R., Renaud, J.-P., & Moras, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402195200 · Cited by 129 · cited 2×
“The new rotamer of phe435 led to a steric clash with Leu454 and phe450 in H12, and displaced H12 (AF-2) from its agonist position capping the LBP [53,54].”
BackgroundTremblay, G. B., Bergeron, D., & Giguere, V. (2001) · Endocrinology · doi:10.1210/endo.142.10.8528 · Cited by 115 · cited 1×
“[52] described that 4-OHT disrupted the interactions between ERR / and co-regulator RIP-140 with IC50 of 500 nM and 90 nM, respectively.”
BackgroundEstrogen-related receptor α as a therapeutic target in cancer
Stein, R. A., & McDonnell, D. P. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.01292 · Cited by 113 · cited 2×
“In addition to this, ERR is also a therapeutic target in cancer [8,9] and osteoporosis [10].”
BackgroundCastet, A., Herledan, A., Bonnet, S., Jalaguier, S., Vanacker, J.-M., & Cavaillès, V. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0227 · Cited by 111 · cited 1×
“The others, ERRs are also modulated by the nuclear receptor corepressor receptor-interacting protein 140 (RIP-140) [32], containing nine LXXLL motif and a non-classical LXXML motif.”
BackgroundTremblay, A. M., Wilson, B. J., Yang, X.-J., & Giguère, V. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0357 · Cited by 105
Zuercher, W. J., Gaillard, S., Orband-Miller, L. A., Chao, E. Y. H., Shearer, B. G., Jones, D. G., Miller, A. B., Collins, J. L., McDonnell, D. P., & Willson, T. M. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050161j · Cited by 103 · cited 1×
“Phenolic acyl hydrazones are the first reported small molecule agonists of ERR and ERR obtained from screening a focused library by FRET assay [69].”
BackgroundStructure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRγ
Chao, E. Y. H., Collins, J. L., Gaillard, S. L., Miller, A. B., Wang, L., Orband‐Miller, L. A., Nolte, R. T., McDonnell, D. P., Willson, T. M., & Zuercher, W. J. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.11.030 · Cited by 97 · cited 2×
“The only difference was the increased hydrogen bonds formed between terminal hydroxyl of GSK5182 and Tyr326 and Asn346 [55].”
BackgroundKallen, J., Lattmann, R., Beerli, R., Blechschmidt, A., Blommers, M. J. J., Geiser, M., Ottl, J., Schlaeppi, J.-M., Strauss, A., & Fournier, B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703337200 · Cited by 95 · cited 2×
“The deactivation mechanism of ERR is different from that of ERR [59].”
BackgroundKaempferol is an estrogen‐related receptor α and γ inverse agonist
Wang, J., Fang, F., Huang, Z., Wang, Y., & Wong, C. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.01.030 · Cited by 93
Barry, J. B., & Giguère, V. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0922 · Cited by 88 · cited 1×
“have also demonstrated that ERR was phosphorylated in response to EGF signaling in breast cancer cells [45].”
BackgroundMolecular Basis for the Constitutive Activity of Estrogen-related Receptor α-1
Chen, S., Zhou, D., Yang, C., & Sherman, M. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102638200 · Cited by 86 · cited 4×
“ERRs activate gene transcription in a constitutive manner in the sense that they do not require a ligand induced conformation changes to bind to co-regulators [5].”
BackgroundMethodInfluentialIdentification of an agonist ligand for estrogen-related receptors ERRβ/γ
Yu, D. D., & FORMAN, B. M. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.01.025 · Cited by 85
Peng, L., Gao, X., Duan, L., Ren, X., Wu, D., & Ding, K. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200976s · Cited by 78
Self-citationEstrogen Receptor-Related Receptor α: A Mediator of Estrogen Response in Bone
Bonnelye, E., & Aubin, J. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2168 · Cited by 77 · cited 1×
“Given the structural and functional similarities between the ERRs and ERs, ERRs have been demonstrated to be involved in ERs signaling pathway of bone formation [47] and osteoblast differentiation [10].”
BackgroundOrphan Nuclear Receptors: An Emerging Family of Metabolic Regulators
SLADEK, R. M., & Giguère, V. (1999) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60109-x · Cited by 65 · cited 1×
“The ERRs have the typical structural feature of ERs, including non-conserved N terminal domain (NTD), DNA binding domain (DBD), hinge region and ligand binding domain (LBD) [20].”
BackgroundPNRC2 is a 16 kDa coactivator that interacts with nuclear receptors through an SH3-binding motif
Zhou, D., & Chen, S. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.19.3939 · Cited by 61 · cited 1×
“One kind is that, ERRs are constitutively activated by p160 family of steroid receptor co-activators SRC-1 family (SRC-1, SRC-2, SRC-3) [26,27], the peroxisome proliferator-activated receptor coactivator-1 (PGC-1 , PGC-1 ) [28,29], and proline rich nuclear receptor co-regulatory protein 2 (PNRC2) [30,31], etc.”
BackgroundStructural activity relationship of flavonoids with estrogen‐related receptor gamma
Huang, Z., Fang, F., Wang, J., & Wong, C.-W. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.11.026 · Cited by 60 · cited 1×
“9) was studied and evaluated as an inverse agonist of ERR and ERR by directly binding to ERRs and suppressing the interactions between ERRs and coactivators [64,65].”
BackgroundZhou, W., Liu, Z., Wu, J., Liu, J.-H., Hyder, S. M., Antoniou, E., & Lubahn, D. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1957 · Cited by 53 · cited 1×
“ERR and ERR have been identified in human [13-15].”
BackgroundERR receptors as potential targets in osteoporosis
Gallet, M., & Vanacker, J.-M. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.06.008 · Cited by 52 · cited 2×
“In addition to this, ERR is also a therapeutic target in cancer [8,9] and osteoporosis [10].”
BackgroundChisamore, M. J., Cunningham, M. E., Flores, O., Wilkinson, H. A., & Chen, J. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005624 · Cited by 45 · cited 1×
“Subsequently, the mechanism of action of compound 31 that inhibited transcriptional activity of ERR was carried out [67].”
BackgroundBonnelye, E., Zirngibl, R. A., Jurdic, P., & Aubin, J. E. (2006) · Endocrinology · doi:10.1210/en.2006-0962 · Cited by 44 · cited 1×
“In the rat cartilage cells, the over expression of ERR can promote chondrocyte differentiation and bone formation, while reduction of ERR with a siRNA led to inhibition of cartilage cell development and cartilage formation in vitro [49].”
BackgroundSLADEK, R. M., Beatty, B., Squire, J. A., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., & Giguère, V. (1997) · Genomics · doi:10.1006/geno.1997.4939 · Cited by 37
Kim, Y., Koh, M., Kim, D.-K., Choi, H.-S., & Park, S. B. (2009) · Journal of Combinatorial Chemistry · doi:10.1021/cc900081j · Cited by 36 · cited 1×
“Based on the above ERR -GSK4716 complex, a series of acyl hydrazone analogues derived from GSK4716 was reported [71,72].”
BackgroundHentschke, M., & Borgmeyer, U. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.025 · Cited by 36 · cited 1×
“One kind is that, ERRs are constitutively activated by p160 family of steroid receptor co-activators SRC-1 family (SRC-1, SRC-2, SRC-3) [26,27], the peroxisome proliferator-activated receptor coactivator-1 (PGC-1 , PGC-1 ) [28,29], and proline rich nuclear receptor co-regulatory protein 2 (PNRC2) [30,31], etc.”
BackgroundAlternative Splicing and Expression of the Mouse Estrogen Receptor-Related Receptor γ
Süsens, U., Hermans‐Borgmeyer, I., & Borgmeyer, U. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1976 · Cited by 35 · cited 1×
“ERR and ERR have been identified in human [13-15].”
BackgroundOn the Intractability of Estrogen-Related Receptor α as a Target for Activation by Small Molecules
Hyatt, S. M., Lockamy, E. L., Stein, R. A., McDonnell, D. P., Miller, A. B., Orband-Miller, L. A., Willson, T. M., & Zuercher, W. J. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm7012387 · Cited by 29 · cited 2×
“Some researches even suggested that ERR may be intractable as a direct target for pharmacologic activation due to the small volume within the ERR LBP [71].”
BackgroundEstrogen-related receptor α (ERRα): A novel target in type 2 diabetes
Handschin, C., & Mootha, V. K. (2005) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2005.05.001 · Cited by 24 · cited 2×
“Extensive genetic and functional studies have highlighted ERR as the main player in oxidative metabolism, a pathway that contributes to the pathology of diabetes [6,7].”
BackgroundLarsen, L. H., Rose, C. S., Sparsø, T., Overgaard, A. J., Torekov, S. S., Grarup, N., Jensen, D. P., Albrechtsen, A., Andersen, G., Ek, J., et al. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803408 · Cited by 23 · cited 1×
“Thus, the development of tissue-specific modulators of ERR may be used for combating diabetes, obesity and other metabolic disease [7,43]”
BackgroundKojo, H., Tajima, K., Fukagawa, M., Isogai, T., & Nishimura, S. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.10.004 · Cited by 19 · cited 1×
“ERR and ERR have been identified in human [13-15].”
BackgroundKoh, M., & Park, S. B. (2010) · Molecular Diversity · doi:10.1007/s11030-010-9224-y · Cited by 11
Estrogen-related receptor alpha as a therapeutic target
Stein, R. A., Way, J. M., McDonnell, D. P., & Zuercher, W. J. (2006) · Drugs of the Future · doi:10.1358/dof.2006.031.05.994706 · Cited by 6
Cited by
Estrogen deficiency and the origin of obesity during menopause
Lizcano, F., & Guzmán, G. (2014) · BioMed Research International · doi:10.1155/2014/757461 · Cited by 586
“Thus, the contribution of estrogen deficiency in the pathobiology of multiple chronic diseases in women is”
BackgroundOestrogen-related receptors in breast cancer: control of cellular metabolism and beyond
Deblois, G., & Giguère, V. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3396 · Cited by 226
Estrogen-related receptors: novel potential regulators of osteoarthritis pathogenesis
Tang, J., Liu, T., Wen, X., Zhou, Z., Yan, J., Gao, J.-P., & Zuo, J. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00270-x · Cited by 58
Overexpression of PGC-1α Influences Mitochondrial Signal Transduction of Dopaminergic Neurons
Ye, Q., Huang, W., Li, D., Si, E., Wang, J., Wang, Y.-Q., Chen, C., & Chen, X. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9299-7 · Cited by 60
Recent Update on the Molecular Mechanisms of Gonadal Steroids Action in Adipose Tissue
Wawrzkiewicz–Jałowiecka, A., Lalik, A., & Soveral, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105226 · Cited by 52
Metadata
- Authors
- Lu, X., Peng, L., Lv, M., & ding, K.
- Affiliations
- Chinese Academy of Sciences (CN)
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2012-08-01
- Volume
- 18
- Issue
- 23
- Pages
- 3421-3431
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2148665241
- Cited by
- 28
- References
- 68
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 1 · 2022: 5 · 2021: 4 · 2020: 2 · 2019: 4 · 2018: 1 · 2015: 3 · 2014: 2 · 2013: 1 · 2012: 1
- FWCI
- 1.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Pharmaceutical Design (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Earth Sciences
- Ministry of Education, India
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- estrogen-related receptors, estrogen-related receptor alpha, ESRRB, estrogen-related receptor gamma, small molecule modulators, inverse agonists, agonists, nuclear receptor ligand-binding domain, co-crystal structure, estrogen signaling, diabetes mellitus, breast cancer, osteoporosis
- MeSH terms
- Receptors, Estrogen, Drug Design, Estrogen Receptor Modulators, Small Molecule Libraries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.